Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9462 |
High Similarity |
NPD1240 |
Approved |
0.9318 |
High Similarity |
NPD1607 |
Approved |
0.9275 |
High Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.9179 |
High Similarity |
NPD1510 |
Phase 2 |
0.9137 |
High Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.9044 |
High Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.9044 |
High Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.8978 |
High Similarity |
NPD1549 |
Phase 2 |
0.8889 |
High Similarity |
NPD6651 |
Approved |
0.8819 |
High Similarity |
NPD4380 |
Phase 2 |
0.8767 |
High Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8759 |
High Similarity |
NPD7411 |
Suspended |
0.8707 |
High Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.8696 |
High Similarity |
NPD2796 |
Approved |
0.8591 |
High Similarity |
NPD7075 |
Discontinued |
0.8561 |
High Similarity |
NPD2935 |
Discontinued |
0.8531 |
High Similarity |
NPD6799 |
Approved |
0.8514 |
High Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8514 |
High Similarity |
NPD7819 |
Suspended |
0.8511 |
High Similarity |
NPD2800 |
Approved |
0.8446 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.8446 |
Intermediate Similarity |
NPD1934 |
Approved |
0.844 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.8403 |
Intermediate Similarity |
NPD1511 |
Approved |
0.8389 |
Intermediate Similarity |
NPD2801 |
Approved |
0.838 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.8345 |
Intermediate Similarity |
NPD2533 |
Approved |
0.8345 |
Intermediate Similarity |
NPD2532 |
Approved |
0.8345 |
Intermediate Similarity |
NPD2534 |
Approved |
0.8321 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.8311 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.8288 |
Intermediate Similarity |
NPD1512 |
Approved |
0.8278 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.8278 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.8258 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.8247 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.8224 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.8205 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.8194 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.8194 |
Intermediate Similarity |
NPD3750 |
Approved |
0.8182 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.8169 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.8125 |
Intermediate Similarity |
NPD1243 |
Approved |
0.8101 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.8099 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.8099 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.8071 |
Intermediate Similarity |
NPD943 |
Approved |
0.8025 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.8025 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.8025 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.8 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.8 |
Intermediate Similarity |
NPD2654 |
Approved |
0.7987 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7987 |
Intermediate Similarity |
NPD920 |
Approved |
0.7987 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7986 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7974 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7959 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7956 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7929 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7905 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7901 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7899 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7885 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7868 |
Intermediate Similarity |
NPD3972 |
Approved |
0.7867 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7852 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7847 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7826 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7812 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7801 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7786 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.777 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7764 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7744 |
Intermediate Similarity |
NPD9493 |
Approved |
0.7737 |
Intermediate Similarity |
NPD9717 |
Approved |
0.7733 |
Intermediate Similarity |
NPD5401 |
Approved |
0.773 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7716 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7703 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7692 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7676 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7673 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7673 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7671 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7671 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7669 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7664 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.7664 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.766 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7647 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7632 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.763 |
Intermediate Similarity |
NPD9545 |
Approved |
0.763 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7622 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7619 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7603 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7595 |
Intermediate Similarity |
NPD919 |
Approved |
0.7576 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7574 |
Intermediate Similarity |
NPD4196 |
Clinical (unspecified phase) |
0.7571 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7571 |
Intermediate Similarity |
NPD1164 |
Approved |
0.7551 |
Intermediate Similarity |
NPD5406 |
Approved |
0.7551 |
Intermediate Similarity |
NPD5404 |
Approved |
0.7551 |
Intermediate Similarity |
NPD5405 |
Approved |
0.7551 |
Intermediate Similarity |
NPD5408 |
Approved |
0.7546 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7536 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7536 |
Intermediate Similarity |
NPD1201 |
Approved |
0.7532 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7517 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7517 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7516 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7516 |
Intermediate Similarity |
NPD5402 |
Approved |
0.75 |
Intermediate Similarity |
NPD1729 |
Discontinued |
0.75 |
Intermediate Similarity |
NPD1247 |
Approved |
0.747 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7467 |
Intermediate Similarity |
NPD7003 |
Approved |
0.7467 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7447 |
Intermediate Similarity |
NPD1470 |
Approved |
0.7442 |
Intermediate Similarity |
NPD4363 |
Phase 3 |
0.7442 |
Intermediate Similarity |
NPD4360 |
Phase 2 |
0.7436 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7399 |
Intermediate Similarity |
NPD4362 |
Clinical (unspecified phase) |
0.7399 |
Intermediate Similarity |
NPD4361 |
Phase 2 |
0.7397 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7376 |
Intermediate Similarity |
NPD1876 |
Approved |
0.7376 |
Intermediate Similarity |
NPD3225 |
Approved |
0.7365 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7365 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.7361 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7361 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7357 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7356 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7324 |
Intermediate Similarity |
NPD3267 |
Approved |
0.7324 |
Intermediate Similarity |
NPD3266 |
Approved |
0.732 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7319 |
Intermediate Similarity |
NPD1651 |
Approved |
0.731 |
Intermediate Similarity |
NPD1296 |
Phase 2 |
0.731 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7279 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7279 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7267 |
Intermediate Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.7259 |
Intermediate Similarity |
NPD1241 |
Discontinued |
0.7254 |
Intermediate Similarity |
NPD1283 |
Approved |
0.7246 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7233 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7226 |
Intermediate Similarity |
NPD5049 |
Phase 3 |
0.7225 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7215 |
Intermediate Similarity |
NPD5890 |
Approved |
0.7215 |
Intermediate Similarity |
NPD5889 |
Approved |
0.7214 |
Intermediate Similarity |
NPD3847 |
Discontinued |
0.7209 |
Intermediate Similarity |
NPD940 |
Approved |
0.7209 |
Intermediate Similarity |
NPD846 |
Approved |
0.7202 |
Intermediate Similarity |
NPD6104 |
Discontinued |
0.7192 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7192 |
Intermediate Similarity |
NPD411 |
Approved |
0.7188 |
Intermediate Similarity |
NPD2296 |
Approved |
0.7188 |
Intermediate Similarity |
NPD4288 |
Approved |
0.7183 |
Intermediate Similarity |
NPD3600 |
Clinical (unspecified phase) |
0.7183 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.7172 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7162 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7161 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7153 |
Intermediate Similarity |
NPD1019 |
Discontinued |
0.7152 |
Intermediate Similarity |
NPD6585 |
Discontinued |
0.7152 |
Intermediate Similarity |
NPD1471 |
Phase 3 |
0.7143 |
Intermediate Similarity |
NPD17 |
Approved |
0.7143 |
Intermediate Similarity |
NPD4626 |
Approved |
0.7143 |
Intermediate Similarity |
NPD74 |
Approved |
0.7143 |
Intermediate Similarity |
NPD9266 |
Approved |
0.7135 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7134 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7122 |
Intermediate Similarity |
NPD1894 |
Discontinued |
0.7113 |
Intermediate Similarity |
NPD1481 |
Phase 2 |
0.711 |
Intermediate Similarity |
NPD4287 |
Approved |
0.7103 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7103 |
Intermediate Similarity |
NPD9494 |
Approved |
0.7095 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7095 |
Intermediate Similarity |
NPD4307 |
Phase 2 |
0.7095 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7089 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7086 |
Intermediate Similarity |
NPD4477 |
Approved |
0.7086 |
Intermediate Similarity |
NPD4476 |
Approved |
0.7078 |
Intermediate Similarity |
NPD3295 |
Clinical (unspecified phase) |
0.7078 |
Intermediate Similarity |
NPD2354 |
Approved |
0.7068 |
Intermediate Similarity |
NPD9264 |
Approved |
0.7068 |
Intermediate Similarity |
NPD9263 |
Approved |
0.7068 |
Intermediate Similarity |
NPD9265 |
Clinical (unspecified phase) |
0.7068 |
Intermediate Similarity |
NPD9267 |
Approved |
0.7066 |
Intermediate Similarity |
NPD7893 |
Clinical (unspecified phase) |
0.7063 |
Intermediate Similarity |
NPD37 |
Approved |
0.7063 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7051 |
Intermediate Similarity |
NPD4661 |
Approved |
0.7051 |
Intermediate Similarity |
NPD4662 |
Approved |
0.7051 |
Intermediate Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.7048 |
Intermediate Similarity |
NPD2403 |
Approved |
0.7047 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7042 |
Intermediate Similarity |
NPD1281 |
Approved |
0.7042
|
Intermediate Similarity |
NPD1535 |
Discovery |